Pharmaceutical - Pharmaceutical, Financial

Filter

Current filters:

PharmaceuticalFinancial

Popular Filters

1 to 25 of 1105 results

Lundbeck to stop further development of desmoteplase

Lundbeck to stop further development of desmoteplase

18-12-2014

Following evaluation of disappointing clinical results, Danish CNS specialists Lundbeck said late yesterday…

Cardio-vasculardesmoteplaseFinancialLundbeckNeurologicalPharmaceuticalResearch

Top 30 Pharmas spent $112 billion on R&D in 2013; report

Top 30 Pharmas spent $112 billion on R&D in 2013; report

17-12-2014

The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development…

FinancialGlobalGlobalDataJohnson & JohnsonNovartisPfizerPharmaceuticalPharmaceutical sciencesResearch

ETH and University of Zurich launch new translational center

ETH and University of Zurich launch new translational center

15-12-2014

Switzerland’s ETH Zurich and the University of Zurich (UZH) are taking their long-standing partnership…

ETH ZurichFinancialPharmaceuticalResearchSwitzerland

Big savings on HIV drugs via pooled procurement expected by Global Fund

Big savings on HIV drugs via pooled procurement expected by Global Fund

12-12-2014

The Global Fund to Fight AIDS, Tuberculosis and Malaria is putting into place a new agreement for purchasing…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalPricing

Savings from extended role exceed NZ$100 million, says NZ’s PHARMAC

Savings from extended role exceed NZ$100 million, says NZ’s PHARMAC

12-12-2014

District Health Boards are poised to save more than $100 million over five years as a result of New Zealand’s…

FinancialHealth Medical PharmaHealthcareNew ZealandPharmaceutical

India revisits plans for free generic medicines, drug price fixing

India revisits plans for free generic medicines, drug price fixing

11-12-2014

Government hospitals in India that lack medicines, are overcrowded and understaffed, may soon be a thing…

FinancialGenericsHealthcareIndiaPharmaceuticalPoliticsPricing

Russia’s R-Pharm to invest $50 million in development of new drugs and vaccines

Russia’s R-Pharm to invest $50 million in development of new drugs and vaccines

11-12-2014

R-Pharm, one of Russia’s largest pharmaceutical producers, together with Russian Venture Company (RVC)…

FinancialPharmaceuticalPharmstandardR-PharmResearchRussia

Africa will be hardest hit region of anti-microbial resistance, warns report

Africa will be hardest hit region of anti-microbial resistance, warns report

11-12-2014

Low income countries are likely to suffer the greatest loss of population and economic output if anti-microbial…

Antibiotics and Infectious diseasesFinancialPharmaceuticalResearchRest of the WorldSub-Saharan Africa

Russian Ministry of Health reveals new classification of drugs for domestic market

Russian Ministry of Health reveals new classification of drugs for domestic market

10-12-2014

The Russian Ministry of Health has designed a new classification of drugs for the domestic pharmaceutical…

FinancialHealthcarePharmaceuticalPharmacologyRussia

Medical burden still heavy for Chinese

10-12-2014

Chinese medical reform fiscal measures have lined the pockets of hospitals and companies but not done…

ChinaFinancialHealthcarePharmaceutical

Medicines Australia welcomes new report on Australian pharma industry

Medicines Australia welcomes new report on Australian pharma industry

10-12-2014

A new report has found that the pharmaceutical and medical technology industries in Australia produce…

AustraliaFinancialMedicines AustraliaPharmaceuticalPharmaceuticals policy

Spanish government should consider linking pharmaceutical spending to GDP growth

Spanish government should consider linking pharmaceutical spending to GDP growth

08-12-2014

Pharmaceutical spending has fallen nearly 30% in Spain in last four years. According to IMS Health data,…

FinancialPharmaceuticalPoliticsPricingSpain

Recently-announced timeline of UK Patent Box changes helps address uncertainty, says patent attorney

04-12-2014

Following UK Chancellor of the Exchequer George Osborne’s confirmation of an overhaul of the Patent…

FinancialPatentsPharmaceuticalResearchUK

ABPI welcomes Chancellor’s decision to increase rate of R&D tax credits

04-12-2014

In his Autumn Statement yesterday, UK Chancellor of the Exchequer, George Osborne said he wants to help…

FinancialPharmaceuticalResearchUK

Bayer boasts strong R&D pipeline and growth prospects

03-12-2014

German pharma major Bayer gave a spirited presentation of its pipeline candidates in both pharma and…

AdempasBayerEyleaFinancialHematologyOncologyOphthalmicsPharmaceuticalResearchStivargaXareltoXofigo

Milestone for Skyepharma as Flutiform debuts in Spain; and as Abriff in Italy

Milestone for Skyepharma as Flutiform debuts in Spain; and as Abriff in Italy

01-12-2014

UK oral and inhalation drug specialist Skyepharma says that, following regulatory approval and agreement…

AbriffFinancialFlutiformItalyJapanKyorin PharmaceuticalMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharmaSpainZambon

AstraZeneca plans further Russian expansion

25-11-2014

Anglo-Swedish pharma major AstraZeneca plans to continue active development on the Russian pharmaceutical…

AstraZenecaFinancialPharmaceuticalProductionRussia

Roche and Lundbeck at the Jefferies 2014 Global Healthcare Conference

Roche and Lundbeck at the Jefferies 2014 Global Healthcare Conference

24-11-2014

Pharma, biotech and health care companies convened in London last week to update investors at the Jefferies…

FinancialHealth Medical PharmaPharmaceuticalRocheUK

Highlights from the Jefferies 2014 Global Healthcare Conference

Highlights from the Jefferies 2014 Global Healthcare Conference

21-11-2014

Pharma, biotech and health care companies convened in London this week to update investors at the Jefferies…

ALK AbelloClinigen GroupCubistFinancialGW PharmaceuticalsPeter GeorgePharmaceuticalUK

Sobi pays $10 million to exercise opt-in right for Elocta

Sobi pays $10 million to exercise opt-in right for Elocta

21-11-2014

Nordic biotech firm Swedish Orphan Biovitrum will exercise its opt-in right to take over final development…

Biogen IdecElocateEloctaFinancialHematologyPharmaceuticalSobiSweden

EMA revises policy on conflict of interests

20-11-2014

The European Medicines Agency has today published its revised policy on handling declarations of interests…

EuropeFinancialPharmaceuticalRegulation

Mallinckrodt 4th-qtr sales and earnings beat analysts’ expectations

20-11-2014

US drugmaker Mallinckrodt has reported a strong set of financial results for the fourth-quarter and full…

FinancialMallinckrodtPharmaceutical

Despite patent cliffs, pharma market shows signs of stability

19-11-2014

The pharmaceutical market is beginning to show signs of stability, with a review of 30 leading companies…

Biogen IdecBoehringer IngelheimFinancialJohnson & JohnsonPatentsPfizerPharmaceutical

Cost of bringing new drug to market now around $2.6 billion, says Tufts CSDD

19-11-2014

Developing a new prescription medicine that gains marketing approval, a process often lasting longer…

FinancialGlobalPharmaceuticalResearch

1 to 25 of 1105 results

Back to top